Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data
Authors
Keywords
-
Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 46, Issue 1, Pages 1-7
Publisher
Informa UK Limited
Online
2020-01-09
DOI
10.1080/03639045.2019.1706552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The importance of buprenorphine research in the opioid crisis
- (2019) Sarah A. Pendergrass et al. MOLECULAR PSYCHIATRY
- Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Barbara R Haight et al. LANCET
- Management of opioid use disorder in the USA: present status and future directions
- (2019) Carlos Blanco et al. LANCET
- Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances
- (2018) Fuschia Serre et al. ADDICTIVE BEHAVIORS
- A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers
- (2018) Saul Alcaraz et al. DRUG AND ALCOHOL DEPENDENCE
- Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment
- (2018) Francisco González-Saiz et al. DRUG AND ALCOHOL DEPENDENCE
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
- (2018) Joshua D Lee et al. LANCET
- Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis
- (2018) Jun Ma et al. MOLECULAR PSYCHIATRY
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder
- (2018) Michelle R. Lofwall et al. JAMA Internal Medicine
- Buprenorphine Pharmacology Review
- (2018) Marion A. Coe et al. Journal of Addiction Medicine
- Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence
- (2017) Kent Hoffman et al. Journal of Addiction Medicine
- Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder
- (2017) Sharon L. Walsh et al. JAMA Psychiatry
- A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities
- (2016) Dan Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder
- (2016) Azmi F. Nasser et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effects of a Higher-bioavailability Buprenorphine/Naloxone Sublingual Tablet Versus Buprenorphine/Naloxone Film for the Treatment of Opioid Dependence During Induction and Stabilization: A Multicenter, Randomized Trial
- (2015) Erik W. Gunderson et al. CLINICAL THERAPEUTICS
- Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy
- (2014) Mark K. Greenwald et al. DRUG AND ALCOHOL DEPENDENCE
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- (2013) Richard N. Rosenthal et al. ADDICTION
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- (2013) Yih-Ing Hser et al. ADDICTION
- Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care
- (2013) S. Apelt et al. PHARMACOPSYCHIATRY
- A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans
- (2012) Shannon Gwin Mitchell et al. DRUG AND ALCOHOL DEPENDENCE
- Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres
- (2008) C. Leonardi et al. DRUG AND ALCOHOL DEPENDENCE
- Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
- (2008) Michael Soyka et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started